FDA
approval
· 2024-05-06
FDA Approved: KAITLIB FE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
Summary
FDA approved a supplemental application for KAITLIB FE (norethindrone and ethinyl estradiol) from Lupin Pharmaceuticals, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for KAITLIB FE (NORETHINDRONE AND ETHINYL ESTRADIOL)